Insulin-Like Growth Factor 1 in the Early Postoperative Assessment of Acromegaly.

Diane Mary DoneganAlicia Algeciras-SchimnichSusan Ashrafzadeh-KianDana Erickson

Published in: American journal of clinical pathology (2021)

Compared with 3 to 6 months, use of IGF-1 at 6 weeks was associated with a change in clinical status in 3.5% of patients. Therefore, in most patients, IGF-1 at 6 weeks can be used to assess clinical outcome via newer assays.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
binding protein
pi k akt